Supportive Treatment With Enhanced Post-Incarceration Services

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCatherine E. Paquette, PhD

About this trial

This study aims to improve health outcomes for people who use drugs after release from incarceration, a period of high risk for overdose and other adverse outcomes. It will examine an individually tailored behavioral activation (IT-BA) intervention integrated into a reentry primary care program with peer support. The goal is to reduce substance use, improve mental health, and increase engagement in healthcare.

Eligibility criteria

Qualifiers

Be aged 18 years or older

Have recent illicit drug use, defined as use of any illegal drug in the past week

Meet DSM-5 criteria for a current (past 12 months) substance use disorder associated with any illegal drug

Have been released from jail or prison (at least 30 consecutive days incarcerated) within the past year

Disqualifiers

Currently engaged in psychosocial treatment for drug use

Unable to speak and understand English

Unable to provide informed consent, including people with severe mental illness requiring immediate treatment or with mental illness limiting their ability to participate (e.g., dementia)

Trial design

Treatments tested in this trial

  • Individually Tailored Behavioral Activation
  • Formerly Incarcerated Transitions Program

Treatment groups

120 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Catherine E. Paquette, PhD

Lead sponsor

Duke University

Sponsor institution

National Institute on Drug Abuse (NIDA)

Collaborator